BRCA1 and breast carcinoma: However, in the Beitsch study [29], it was shown that if genetic tests were performed only based on the NCCN Criteria, and when only the BRCA1/2 or limited panels were tested, about 45% of breast cancer patients with germline variants would be ignored.